“CRISPR-CAS9 GENE EDITING THERAPEUTICS: FROM FIRST APPROVAL TO EXPANDING CLINICAL PIPELINE”, GCM, vol. 1, no. 9, pp. 29–36, Sep. 2026, Accessed: Sep. 15, 2026. [Online]. Available: http://econferencia.com/index.php/5/article/view/1409